Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: a randomised study - Concepedia

Concepedia

Publication | Closed Access

Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: a randomised study

77

Citations

32

References

2007

Year

Chen‐Hua Liu, C-C Liang, J-W Lin, Si Chen, H-B Tsai, Chang Cs, P-H Hung, Jia‐Horng Kao, Chun‐Jen Liu, Lai My,

Abstract

Pegylated interferon alpha-2a once weekly provides more effective and safer therapy than standard interferon alpha-2a thrice weekly for treatment-naive dialysis patients with chronic hepatitis C.

References

	Year	Citations

Page 1